Abstract
AIM: To investigate the efficacy of ursodeoxycholic acid (UDCA) in Chinese patients with advanced primary biliary cirrhosis (PBC). METHODS: 55 PBC in-patients were treated with UDCA(1000mg/day) for 12 days(12.7±3.7 days). The biochemical response to UDCA treatment was evaluated before and after after treatment. RESULTS: Biochemical markers such as ALT, AST, ALP, GGT , TP, ALB, GLO,TBA, TBIL, DBIL were not improved significantly. During the therapy, no severe adverse effects leading to discontinuing the treatment were observed. CONCLUSIONS: UDCA is not effective for improving liver biochemical tests in patients with advanced PBC for short duration.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Gastroenterology and Hepatology Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
